Matches in SemOpenAlex for { <https://semopenalex.org/work/W1576587364> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W1576587364 endingPage "1083" @default.
- W1576587364 startingPage "1083" @default.
- W1576587364 abstract "4613 Peritoneal diffuse malignant mesothelioma is a rare neoplasm characterized by a poor prognosis, which is not modified by conventional anticancer treatments. Since resistance to apoptosis is considered a major mechanism in tumor progression and drug resistance, we examined the expression of anti-apoptotic (Bcl-2, Bcl-X L , survivin, c-IAP 1 , c-IAP 2 and X-IAP) and pro-apoptotic (SMAC/Diablo) proteins by immunohistochemistry in 32 peritoneal diffuse malignant mesothelioma specimens. Overexpression of survivin and other IAP proteins was observed in a high percentage of tumors (range of positivity rate: 69-100%) and in an elevated fraction of tumor cells. Bcl-2 and Bcl-X L were also expressed in a high fraction of cases (66% and 82%, respectively), with high intensity immunostaining, whereas SMAC/Diablo immunostaining was detectable in only 34% of tumors. Accordingly, a low apoptotic index (median percentage of M30-positive cells, 0.45%; range, 0.01-5.8%) was consistently observed. To investigate whether anti-apoptotic proteins represent potential targets for new therapeutic interventions in this disease, we tested the effects of survivin knockdown accomplished through RNA interference in a peritoneal mesothelioma cell line. Cells were transfected with 100 nM of a 21-mer double-stranded small interfering RNA (siRNA) targeting survivin mRNA for 8 h, and the effects of cell transfection with siRNA on mesothelioma cell phenotype were evaluated at different time points. A strong inhibition (> 80%) of survivin expression at mRNA and protein levels was observed, which was followed by a time-dependent reduction of cell growth and a significant increase of caspase-9-mediated apoptotic rate. Moreover, sequential exposure of siRNA-transfected mesothelioma cells to anticancer drugs (cisplatin and doxorubicin) induced additive antiproliferative effects and markedly increased the apoptotic response to individual drug treatment. Overall, our results indicate that peritoneal diffuse malignant mesothelioma is characterized by deregulation of apoptosis pathways, in terms of increased expression of anti-apoptotic proteins, and suggest that strategies aimed at interfering with such proteins may provide a novel approach for the treatment of this malignancy." @default.
- W1576587364 created "2016-06-24" @default.
- W1576587364 creator A5017063301 @default.
- W1576587364 creator A5038502087 @default.
- W1576587364 creator A5051849008 @default.
- W1576587364 creator A5068045235 @default.
- W1576587364 creator A5072486452 @default.
- W1576587364 creator A5084587373 @default.
- W1576587364 creator A5089021391 @default.
- W1576587364 date "2006-04-15" @default.
- W1576587364 modified "2023-09-24" @default.
- W1576587364 title "Potential of survivin as a new therapeutic target in diffuse malignant mesothelioma of the peritoneum" @default.
- W1576587364 hasPublicationYear "2006" @default.
- W1576587364 type Work @default.
- W1576587364 sameAs 1576587364 @default.
- W1576587364 citedByCount "2" @default.
- W1576587364 crossrefType "journal-article" @default.
- W1576587364 hasAuthorship W1576587364A5017063301 @default.
- W1576587364 hasAuthorship W1576587364A5038502087 @default.
- W1576587364 hasAuthorship W1576587364A5051849008 @default.
- W1576587364 hasAuthorship W1576587364A5068045235 @default.
- W1576587364 hasAuthorship W1576587364A5072486452 @default.
- W1576587364 hasAuthorship W1576587364A5084587373 @default.
- W1576587364 hasAuthorship W1576587364A5089021391 @default.
- W1576587364 hasConcept C142724271 @default.
- W1576587364 hasConcept C173396325 @default.
- W1576587364 hasConcept C190283241 @default.
- W1576587364 hasConcept C204232928 @default.
- W1576587364 hasConcept C22615655 @default.
- W1576587364 hasConcept C2775975398 @default.
- W1576587364 hasConcept C2777407522 @default.
- W1576587364 hasConcept C2777408456 @default.
- W1576587364 hasConcept C2778995398 @default.
- W1576587364 hasConcept C31573885 @default.
- W1576587364 hasConcept C4224716 @default.
- W1576587364 hasConcept C502942594 @default.
- W1576587364 hasConcept C54009773 @default.
- W1576587364 hasConcept C54355233 @default.
- W1576587364 hasConcept C55493867 @default.
- W1576587364 hasConcept C71924100 @default.
- W1576587364 hasConcept C81885089 @default.
- W1576587364 hasConcept C86803240 @default.
- W1576587364 hasConceptScore W1576587364C142724271 @default.
- W1576587364 hasConceptScore W1576587364C173396325 @default.
- W1576587364 hasConceptScore W1576587364C190283241 @default.
- W1576587364 hasConceptScore W1576587364C204232928 @default.
- W1576587364 hasConceptScore W1576587364C22615655 @default.
- W1576587364 hasConceptScore W1576587364C2775975398 @default.
- W1576587364 hasConceptScore W1576587364C2777407522 @default.
- W1576587364 hasConceptScore W1576587364C2777408456 @default.
- W1576587364 hasConceptScore W1576587364C2778995398 @default.
- W1576587364 hasConceptScore W1576587364C31573885 @default.
- W1576587364 hasConceptScore W1576587364C4224716 @default.
- W1576587364 hasConceptScore W1576587364C502942594 @default.
- W1576587364 hasConceptScore W1576587364C54009773 @default.
- W1576587364 hasConceptScore W1576587364C54355233 @default.
- W1576587364 hasConceptScore W1576587364C55493867 @default.
- W1576587364 hasConceptScore W1576587364C71924100 @default.
- W1576587364 hasConceptScore W1576587364C81885089 @default.
- W1576587364 hasConceptScore W1576587364C86803240 @default.
- W1576587364 hasLocation W15765873641 @default.
- W1576587364 hasOpenAccess W1576587364 @default.
- W1576587364 hasPrimaryLocation W15765873641 @default.
- W1576587364 hasRelatedWork W1971487741 @default.
- W1576587364 hasRelatedWork W1984382819 @default.
- W1576587364 hasRelatedWork W1989803506 @default.
- W1576587364 hasRelatedWork W2008451404 @default.
- W1576587364 hasRelatedWork W2029171625 @default.
- W1576587364 hasRelatedWork W2074504267 @default.
- W1576587364 hasRelatedWork W2102531624 @default.
- W1576587364 hasRelatedWork W2103579767 @default.
- W1576587364 hasRelatedWork W2160470348 @default.
- W1576587364 hasRelatedWork W2353117859 @default.
- W1576587364 hasRelatedWork W2359535677 @default.
- W1576587364 hasRelatedWork W2468990645 @default.
- W1576587364 hasRelatedWork W2501225154 @default.
- W1576587364 hasRelatedWork W2737262628 @default.
- W1576587364 hasRelatedWork W2778937101 @default.
- W1576587364 hasRelatedWork W2788509615 @default.
- W1576587364 hasRelatedWork W2900435384 @default.
- W1576587364 hasRelatedWork W2940600165 @default.
- W1576587364 hasRelatedWork W2565192028 @default.
- W1576587364 hasRelatedWork W2741475273 @default.
- W1576587364 hasVolume "66" @default.
- W1576587364 isParatext "false" @default.
- W1576587364 isRetracted "false" @default.
- W1576587364 magId "1576587364" @default.
- W1576587364 workType "article" @default.